GENERAL - PELVIC ORGAN PROLAPSE
Payment Trends by Year
| Year | Amount | Transactions | Doctors |
|---|---|---|---|
| 2022 | $182,055 | 10 | 0 |
| 2021 | $172.22 | 3 | 3 |
| 2020 | $356,112 | 155 | 79 |
| 2019 | $102,405 | 14 | 10 |
| 2018 | $49,024 | 3 | 1 |
| 2017 | $474,244 | 617 | 227 |
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Grant | $420,388 | 40 | 36.1% |
| Unspecified | $388,972 | 10 | 33.4% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $128,023 | 20 | 11.0% |
| Consulting Fee | $115,606 | 57 | 9.9% |
| Travel and Lodging | $75,188 | 305 | 6.5% |
| Food and Beverage | $35,239 | 367 | 3.0% |
| Education | $597.45 | 3 | 0.1% |
Payments by Type
Research Studies & Clinical Trials
| Study Name | Sponsor | Amount | Doctors |
|---|---|---|---|
| Randomized trial of Retropubic versus Single incision Mid Urethral Sling Solyx for Concomitant Management of Stress Urinary Incontinence during Minimally Invasive Sacrocolpopexy | BOSTON SCIENTIFIC CORPORATION | $170,000 | 0 |
| Permanent versus delayedabsorbable monofilament suture for vaginal graft attachment during minimallyinvasive total hysterectomy and sacrocolpopexy | BOSTON SCIENTIFIC CORPORATION | $52,500 | 0 |
| Randomized trial of Retropubic versus Singleincision MidUrethral Sling Solyx for Concomitant Management of Stress Urinary Incontinence during Minimally Invasive Sacrocolpopexy | BOSTON SCIENTIFIC CORPORATION | $45,000 | 0 |
| Permanent versus delayed absorbable monofilament suture for vaginal graft attachment during minimally invasive total hysterectomy and sacrocolpopexy A Randomized Clinical Trial | BOSTON SCIENTIFIC CORPORATION | $30,500 | 0 |
| ISROTH40019 | Boston Scientific Corporation | $25,000 | 0 |
| SCP vs HUSLS for Pelvic Organ Prolapse Repair | Boston Scientific Corporation | $24,000 | 0 |
| Cadaver Study of the SSLF and Prudendal Nerve Block | BOSTON SCIENTIFIC CORPORATION | $14,850 | 0 |
| eVAULT Washington DC Human Subject FDA Approved No new indication | BOSTON SCIENTIFIC CORPORATION | $13,987 | 0 |
| Permanent vs delayed absorbable monofilament suture | BOSTON SCIENTIFIC CORPORATION | $13,135 | 0 |
Top Doctors Receiving Payments for GENERAL - PELVIC ORGAN PROLAPSE
| Doctor | Specialty | Location | Total | Records |
|---|---|---|---|---|
| Unknown | — | Hartford, CT | $717,860 | 43 |
| , M.D | Surgery | Pontiac, IL | $35,000 | 1 |
| , M.D | Student in an Organized Health Care Education/Training Program | Hanover, MD | $25,000 | 1 |
| , MD | Urogynecology and Reconstructive Pelvic Surgery | Charlotte, NC | $23,765 | 15 |
| , M.D | Obstetrics & Gynecology | Columbia, SC | $22,771 | 10 |
| , DO | Obstetrics & Gynecology | Hartford, CT | $16,744 | 11 |
| , MD | Urogynecology and Reconstructive Pelvic Surgery | Maryville, IL | $15,467 | 8 |
| Brandon Sass | Obstetrics & Gynecology | Houston, TX | $15,000 | 1 |
| , M.D | Urology | Seattle, WA | $13,397 | 4 |
| , M.D | Specialist | Orange, CA | $11,996 | 10 |
| , M.D | Obstetrics & Gynecology | Los Gatos, CA | $11,366 | 10 |
| , MD | Obstetrics & Gynecology | Sioux Falls, SD | $10,483 | 5 |
| , M.D | Urogynecology and Reconstructive Pelvic Surgery | Allentown, PA | $9,776 | 6 |
| , M.D | Urogynecology and Reconstructive Pelvic Surgery | Allentown, PA | $9,742 | 8 |
| , MD | Urogynecology and Reconstructive Pelvic Surgery | Winston Salem, NC | $9,183 | 10 |
| , MD | Urogynecology and Reconstructive Pelvic Surgery | Cambridge, MA | $9,017 | 15 |
| , MD | Urogynecology and Reconstructive Pelvic Surgery | Franklin, TN | $8,828 | 7 |
| , MD | Gynecology | Pompano Beach, FL | $8,570 | 9 |
| , MD | Urogynecology and Reconstructive Pelvic Surgery | Great Neck, NY | $8,424 | 8 |
| , M.D | Urogynecology and Reconstructive Pelvic Surgery | Cleveland, OH | $7,928 | 4 |
| , MD | Urogynecology and Reconstructive Pelvic Surgery | Cleveland, OH | $7,880 | 4 |
| Elizabeth Mueller | Urology | Maywood, IL | $7,513 | 5 |
| , MD | Urology | Beverly Hills, CA | $7,484 | 9 |
| , M.D | Gynecology | Bay Minette, AL | $7,205 | 6 |
| , M.D | Obstetrics & Gynecology | Washington, DC | $7,031 | 6 |
Manufacturing Companies
- BOSTON SCIENTIFIC CORPORATION $883,480
- Boston Scientific Corporation $280,532
Product Information
- Type Device
- Total Payments $1.2M
- Total Doctors 298
- Transactions 802
About GENERAL - PELVIC ORGAN PROLAPSE
GENERAL - PELVIC ORGAN PROLAPSE is a device associated with $1.2M in payments to 298 healthcare providers, recorded across 802 transactions in the CMS Open Payments database. The primary manufacturer is BOSTON SCIENTIFIC CORPORATION.
Payment data is available from 2017 to 2022. In 2022, $182,055 was paid across 10 transactions to 0 doctors.
The most common payment nature for GENERAL - PELVIC ORGAN PROLAPSE is "Grant" ($420,388, 36.1% of total).
GENERAL - PELVIC ORGAN PROLAPSE is associated with 9 research studies, including "Randomized trial of Retropubic versus Single incision Mid Urethral Sling Solyx for Concomitant Management of Stress Urinary Incontinence during Minimally Invasive Sacrocolpopexy" ($170,000).